Systemic lupus erythematosus: causative factors and treatment.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000378:metabolism; D003165:Complement System Proteins; D004347:Drug Interactions; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007239:Infections / Q000150:complications; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000209:etiology* / Q000276:immunology / Q000503:physiopathology / Q000628:therapy
D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D007166:Immunosuppressive Agents; D003165:Complement System Proteins; D002097:C-Reactive Protein